Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Pfizer (NYSE:PFE) Trading Up 0.4% – Time to Buy?
FDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
Pfizer Gains FDA Approval for Colorectal-Cancer Treatment | Morningstar
Pfizer (NYSE:PFE) Trading Up 1.6% - What's Next?
Principal Financial Group Inc. Sells 1,349,308 Shares of Pfizer Inc. (NYSE:PFE)
Applied Therapeutics CEO Steps Down, Les Funtleyder Appointed As Interim CEO | Markets Insider
Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now?
Leerink Partnrs Estimates Pfizer's Q3 Earnings (NYSE:PFE)
Principal Financial Group Inc. Decreases Stake in Pfizer Inc. (NYSE:PFE)
The Biggest CMO Moves of 2024
FDA approves new first-line treatment for BRAF V600E mCRC By Investing.com
Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals - December 20, 2024 - Zacks.com
Aadi Bioscience adds Baiteng Zhao to board
Pfizer (NYSE:PFE) Trading 0.4% Higher - Time to Buy?
Pfizer Inc (PFE) Announces Upcoming Webcast for Fourth Quarter and Full Year 2024 Performance Report
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts | Morningstar
Pfizer (NYSE:PFE) Issues FY25 Earnings Guidance
Local Anesthesia Drugs Market Drivers: Technological Advances Transforming Pain Relief Options – Express Press Release Distribution
Pfizer's SWOT analysis: stock outlook amid pipeline progress and cost cuts By Investing.com
Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around?
IMS Capital Management Has $3.02 Million Stock Position in Pfizer Inc. (NYSE:PFE)
Truist Financial Issues Pessimistic Forecast for Pfizer (NYSE:PFE) Stock Price
Pfizer (NYSE:PFE) Trading Up 0.5% – What’s Next?
Truist cuts Pfizer shares target, retains buy rating on growth projections By Investing.com
Pfizer reiterated at Market Perform by analyst following FY25 guidance By Investing.com
Pfizer (NYSE:PFE) Issues FY 2024 Earnings Guidance
Syntax Research Inc. Reduces Position in Pfizer Inc. (NYSE:PFE)
Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox
Pfizer (NYSE:PFE) Updates FY 2025 Earnings Guidance
Arvinas's SWOT analysis: biotech firm's stock faces pivotal trial results By Investing.com
BlinkLab Limited (ASX: BB1) – Trading Halt
Cautious Hold Rating for Pfizer Amidst Stable Near-Term Outlook and Long-Term Concerns
Pfizer’s Balanced Outlook: Hold Rating Amid Uncertainties and Growth Potential
Pfizer’s Stable Outlook Amid Growth Challenges and Policy Risks Leads to Hold Rating
Stocks To Watch: NHPC, Reliance Power, Ambuja Cements, Exide Industries, REC, Jindal Saw, Pfizer, Granules India
News Highlights: Top Company News of the Day - Tuesday at 5 PM ET | Morningstar
Pfizer (NYSE:PFE) Trading Up 4% - Here's What Happened
News Highlights: Top Company News of the Day - Tuesday at 3 PM ET | Morningstar
News Highlights: Top Company News of the Day - Tuesday at 1 PM ET | Morningstar
Pfizer (NYSE:PFE) Shares Gap Up – Still a Buy?
Pfizer (NYSE:PFE) Shares Gap Up - Still a Buy?
Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030
Pfizer On Pace for Largest Percent Increase Since May — Data Talk | Morningstar
HEALTHCARE: Pfizer (PFE: A2/A): 2025 Guidance
Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion
Pfizer (NYSE:PFE) Issues FY24 Earnings Guidance
Pfizer (NYSE:PFE) Updates FY25 Earnings Guidance
Stocks making the biggest moves premarket: PFE, TSLA, SEDG, RCAT and more
Pfizer Sees 2025 Revenue in Line With Wall Street Views — Update | Morningstar
In relief for investors, Pfizer 2025 profit forecast in line with estimates | Company News - Business Standard
Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise By Investing.com
Pfizer (NYSE:PFE) Releases FY 2025 Earnings Guidance
Pfizer Sees 2025 Revenue in Line With Wall Street Views, Despite Hit from Benefit Changes | Morningstar
Pfizer’s In-Line Guidance Offers Relief to Weary Investors
Is Pfizer Inc. (PFE) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround
Pfizer Expects 2025 Adj. EPS Operational Growth Of 10% To 18%; Reaffirms 2024 Guidance
US health-care stocks dip on Trump's commitment to PBM reform By Investing.com
10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar
Pfizer projects 2025 earnings to align with expectations By Investing.com
Lava Therapeutics' SWOT analysis: stock faces challenges after key asset discontinuation By Investing.com
Wall Street today: US stocks slip after strong retail sales data, Nvidia dips 3.5%, Pfizer jumps 4%
Pfizer CEO: Trump 'Very Proud' Of COVID Vaccine 12/18/2024
Wall Street: US stocks slip after strong retail sales data, Nvidia dips 3.5%, Pfizer jumps 4% - Why markets are falling
Symbol: PFE Security name: Pfizer CDR (CAD Hedged) Status:
Pfizer (NYSE:PFE) Trading Up 0.5% - Here's Why
Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential By Investing.com
Pfizer (PFE) Gets a Hold from Wells Fargo | Markets Insider
Pfizer's SWOT analysis: stock outlook amid pipeline progress and market challenges By Investing.com
Sangamo Therapeutics' SWOT analysis: gene therapy firm's stock faces hurdles By Investing.com
Beaird Harris Wealth Management LLC Reduces Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer (PFE) Is Too Cheap To Ignore
Pfizer Inc. (NYSE:PFE) Position Trimmed by B. Riley Wealth Advisors Inc.
Franklin Resources Inc. Has $477.76 Million Position in Pfizer Inc. (NYSE:PFE)
Tidal Investments LLC Grows Holdings in Pfizer Inc. (NYSE:PFE)
World Investment Advisors LLC Purchases 48,281 Shares of Pfizer Inc. (NYSE:PFE)
Inspire Trust Co. N.A. Purchases 14,891 Shares of Pfizer Inc. (NYSE:PFE)
Truist sees upside in Sangamo stock with milestone payments and Fabry disease advancements By Investing.com
Pfizer (NYSE:PFE) Stock Price Up 0.3% After Dividend Announcement
Copley Financial Group Inc. Buys New Stake in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by Denver PWM LLC
Cim Investment Management Inc. Reduces Holdings in Pfizer Inc. (NYSE:PFE)
Synovus Financial Corp Acquires 78,675 Shares of Pfizer Inc. (NYSE:PFE)
Sanctuary Advisors LLC Has $22.35 Million Holdings in Pfizer Inc. (NYSE:PFE)
Q1 Earnings Estimate for Pfizer Issued By Leerink Partnrs
51,783 Shares in Pfizer Inc. (NYSE:PFE) Bought by Virtu Financial LLC
Y Intercept Hong Kong Ltd Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Increases Dividend to $0.43 Per Share
Pfizer Inc (PFE) Announces Increase in Quarterly Dividend for Q1 2025
Moderna Stays Upbeat As Anti-Vaxxers Prepare To Rule In D.C. 12/12/2024
Pfizer Boost Quarter Dividend by 2.4% to 43 Cents | Morningstar
Pfizer Declares First-Quarter 2025 Dividend | Morningstar
Leerink Partnrs Has Negative Outlook for Pfizer Q4 Earnings
Pfizer (NYSE:PFE) Trading Up 0.8% - Time to Buy?
Pfizer Inc. (NYSE:PFE) Shares Sold by Sunbelt Securities Inc.
TD Private Client Wealth LLC Acquires 3,307 Shares of Pfizer Inc. (NYSE:PFE)
Latest news
Analyst revises Amazon stock forecast following major 'moonshot' initiative
Stock market today: Nasdaq Hits Record Highs as Tesla Achieves New Peaks